Hormonal Factors and the Risk of Breast Cancer According to Estrogen- and Progesterone-Receptor Subgroup

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 10, 2003, Pages 1053-1060

  Cotterchio, Michelle ^a,b   Kreiger, Nancy ^a,b   Theis, Beth ^a   Sloan, Margaret ^a   Bahl, Saira ^a,b  

^a CANCER CARE ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ESTROGEN RECEPTOR; HORMONE; PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANADA; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; MULTIVARIATE ANALYSIS; OBESITY; ONSET AGE; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGED; ALCOHOL DRINKING; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; OBESITY; ODDS RATIO; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0142212206     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Key, T. J. A., and Pike, M. C. The role of oestrogen and progestagens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin Oncol., 24: 29-34, 1988.
2. Thomas, H. V., Reeves, G. K., and Key, T. J. A. Endogenous estrogen and post-menopausal breast cancer: a quantitative review. Cancer Causes Control, 8: 922-928, 1997.
3. Lippman, M. E., and Dickson, R. B. Mechanism of normal and malignant breast epithelial growth regulation. J. Steroid Biochem., 34: 107-121, 1989.
4. Osborne, M. P., Bradlow, H. L., Wong, G. Y. C., and Telang, N. T. Upregulation of estradiol C16-α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl. Cancer Inst. (Bethesda), 85: 1917-1920, 1993.
5. Henderson, B. E., Pike, M. C., Bernstein, L., and Ross, R. K. Breast cancer. In: D. Schottenfeld and J. F. Fraumeni (eds.), Cancer Epidemiology and Prevention, Ed. 2. New York, Oxford University Press, 1996.
6. Goodman, H. M. (ed.). Basic Medical Endocrinology. New York: Raven Press, 1988.
7. Brody, T., Lamer, J., Minnerman, K., and Neu, H. Human Pharmacology. Molecular to Clinical. MS: Mosby-Year Book, Inc., St. Louis, USA, 1994.
8. Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. Estrogens, progestogens, normal breast proliferation, and breast cancer risk. Epidemiol. Rev., 15: 17-35, 1993.
9. Ricketts, D., Turnbull, L., Ryall, G., Bakhshi, R., Rawson, N. S., Gazet, J. C., Nolan, C., and Coombes, R. C. Estrogen and progesterone receptors in the normal female breast. Cancer Res., 51: 1817-1822, 1991.
10. McCarty, K. S. J., Silva, J. S., Cox, E. B., Leight, G. S., Wells, S. A., and McCarty, K. S. Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann. Surg., 197: 123-127, 1983.
11. Huang, W. Y., Newman, B., Millikan, R. C., Schell, M. J., Hulka, B. S., and Moorman, P. G. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am. J. Epidemiol., 151: 703-714, 2000.
12. Hsieh, C., Trichopoulos, D., Katsouyanni, K., and Yuasa, S. Age at menarche, age at menopause, height, and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int. J. Cancer, 46: 796-800, 1990.
13. Kelsey, J. L., Gammon, M. D., and John, E. M. Reproductive factors and breast cancer. Epidemiol. Rev., 15: 36-47, 1993.
14. Kelsey, J. L., and Bernstein, L. Epidemiology and prevention of breast cancer. Annu. Rev. Public Health, 17: 47-67, 1996.
15. Collaborative Group on Hormonal Factors in Breast Cancer (CGHFBC). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047-1059, 1997.
16. Stanford, J. A., Weiss, N. S., Voigt, L. F., Daling, J. R., Habel, L. A., and Rossing, M. A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J. Am. Med. Assoc., 274: 137-142, 1995.
17. Newcomb, P. A., Longnecker, M. P., Storer, B. E., Mittendorf, R., Baron, J., Clapp, R. W., Bogdan, G., and Willett, W. C. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am. J. Epidemiol., 142: 788-795, 1995.
18. Risch, H. A., and Howe, G. R. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study. Am. J. Epidemiol., 139: 670-683, 1994.
19. Colditz, G., and Rosner, B. Use of estrogen plus progestin is associated with greater increase in breast cancer risk than estrogen alone. Am. J. Epidemiol., 147 (11S): S64, 1998.
20. Malone, K. E., Daling, J. R., and Weiss, N. S. Oral contraceptives in relation to breast cancer. Epidemiol. Rev., 15: 80-97, 1993.
21. Potter, J. D., Cerhan, J. R., Sellers, T. A., McGovern, P. G., Drinkard, C., Kushi, L. R., and Folsom, A. R. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol. Biomark. Prev., 4: 319-326, 1995.
22. Enger, S., Ross, R., Paganini-Hill, A., Carpenter, C., and Bernstein, L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol. Biomark. Prev., 9: 681-687, 2000.
23. Yoo, K. Y., Tajima, K., Miura, S., Takeuchi, T., Hirose, K., Risch, H., and Dabrow, R. Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am. J. Epidemiol., 146: 307-314, 1997.
24. Britton, J., Gammon, M., Schoenberg, J., Stanford, J., et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am. J. Epidemiol., 156: 507-516, 2002.
25. Yoo, K. Y., Tajima, K., Park, S., Kang, D., et al. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett., 167: 57-63, 2001.
26. Manjer, J., Malina, J., Berglund, G., et al. Smoking associated with hormone receptor negative breast cancer. Int. J. Cancer, 91: 580-584, 2001.
27. McTiernan, A., Thomas, D. B., Johnson, L. K., and Roseman, D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J. Natl. Cancer Inst. (Bethesda), 77: 849-854, 1986.
28. Kreiger, N., King, W. D., Rosenberg, L., Clarke, E. A., Palmer, J. R., and Shapiro, S. Steroid receptor status and the epidemiology of breast cancer. Ann. Epidemiol., 1: 513-523, 1991.
29. Cotterchio, M., Kreiger, N., Sloan, M., and Steingart, A. Non-steroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 1213-1217, 2001.
30. Johnson, K. C., Mao, Y., Argo, J., Dubois, S., Semenciw, R., Lava, J., and the Canadian Cancer Registries Epidemiology Research Group. The National Enhanced Cancer Surveillance System: a case-control approach to environment-related cancer surveillance in Canada. Environmetrics 9: 495-504, 1998.
31. Robles, S., Marrett, L., Clarke, E., and Risch, H. An application of capture-recapture methods to the estimation of completeness of cancer registries. J. Clin. Epidemiol., 41: 495-501, 1988.
32. Holowaty, E. J., Lee, G., Dale, D., and Chong, N. A reabstraction study to estimate the accuracy and completeness of data elements in the Ontario Cancer Registry. American Association of Central Cancer Registries. Niagara-on-the-Lake, Ontario, 1994.
33. Ryan, E. D., Clark, A. F., Mobbs, B. G., Ooi, T. C., Sutherland, D. J., and Tustanoff, E. R. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosol. Clin. Biochem., 18: 20-26, 1985.
34. Stierer, M., Rosen, H., Weber, R., Hanak, H., Auerbach, L., Spona, J., and Tuchler, H. Comparison of immunohistochemical and biochemical measurement of steroid receptors in primary breast cancer: evaluation of discordant findings. Breast Cancer Res. Treat., 50: 125-134, 1998.
35. Stata 7.0. Stata Corporation. College Station, Texas, 2001.
36. Maldonado, G., and Greenland, S. Simulation study by confounder-selection strategies. Am. J. Epidemiol., 138: 923-936, 1993.
37. Moolgavkar, S. H., Day, N. E., and Stevens, R. G. Two stage model for carcinogenesis: epidemiology of breast cancer in females. J. Natl. Cancer Inst. (Bethesda), 65: 559-569, 1980.
38. Musey, V. C., Collins, D. C., Brogan, D. R., Santos, V. R., Musey, P. I., Martino-Saltzman, D., and Preedy, J. R. Long-term effects of a first pregnancy on the hormonal environment: estrogens and androgens. J. Clin. Endocrinol. Metab., 64: 111-118, 1987.
39. Musey, V. C., Collins, D. C., Musey, P. L., Martino-Saltzman, D., and Preedy, J. R. Long-term effects of a first pregnancy on the secretion of prolactin. N. Engl. J. Med., 316: 229-234, 1987.
40. Russo, I. H., and Russo, J. Physiological bases of breast cancer prevention. Eur. J. Cancer Prev., 2 (Suppl. 3): 101-111, 1993.
41. Cleland, W. H., Mendelson, C. R., and Simpson, E. R. Effects of aging and obesity on aromatase activity of human adipose cells. J. Clin. Endocrinol. Metab, 69: 174-177, 1985.
42. Smith-Warner, S., Spiegelman, D., Yaun, S., et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. J. Am. Med. Assoc., 279: 535-540, 1998.
43. Ellison, R. C., Zhang, Y., McLennan, and Rothman, K. Exploring the relation of alcohol consumption to risk of breast cancer. Am. J. Epidemiol., 154: 740-747, 2001.
44. Singletary, K., and Gapstur, S. Alcohol and breast cancer. Review of epidemiologic and experimental evidence and potential mechanisms. J. Am. Med. Assoc., 286: 2143-2151, 2001.
45. Lipworth, L., Bailey, L. R., and Trichopoulos, D. History of breast feeding in relation to breast cancer risk: a review of the epidemiologic literature. J. Natl. Cancer Inst. (Bethesda), 92: 302-312, 2000.
46. Kreiger, N., Cotterchio, M., Steingart, A., and Buchan, G. Antidepressant medication use and breast cancer risk. Am. J. Epidemiol., 151: S27, 2000.
47. Palmieri, C., Cheng, G., Saji, S., et al. Estrogen receptor β in breast cancer. Endoc. Relat. Cancer, 9: 1-13, 2002.